文献速递分子诊断临床微生物

开发评分系统识别细菌广谱16S rRNA基因PCR测序高产出标本

Development of a scoring system to identify high-yield specimens for bacterial broad-range 16S rRNA gene PCR with sequencing at a tertiary care medical center.
PubMed 文献 · Am J Clin Pathol · 2023-01-01

该研究回顾性分析三级医疗中心86例细菌广谱PCR测序(BRBPS)医嘱,采用感染标志物评分系统(VIO评分)预测可操作诊断数据。低VIO评分标本仅10%检出病原体,其中33%视为污染,85%病例仍继续广谱抗菌治疗;高VIO评分标本阳性更可预测,检出病原体均视为致病菌,并提供靶向或降阶梯治疗机会。

要点

  • 低VIO评分标本BRBPS阳性率仅10%,阳性中33%为污染。
  • 高VIO评分标本BRBPS阳性更可预测,检出菌均视为致病菌。
  • VIO评分可辅助识别高产出标本,优化BRBPS使用。

核心结论

  • VIO评分系统有助于识别BRBPS高产出标本并指导其合理使用。

研究设计与样本

  • 回顾性分析三级医疗中心86例BRBPS医嘱,通过病历回顾评估高或低VIO评分标本结果对临床管理的影响。

主要发现

  • 低VIO评分标本仅10%检出病原体,其中33%阳性结果视为污染。
  • 低VIO评分且BRBPS阴性病例中,85%仍继续广谱抗菌治疗。
  • 高VIO评分标本BRBPS阳性更可预测,检出病原体均视为致病菌,并提供靶向或降阶梯治疗机会。

临床怎么用

  • 可参考VIO评分识别高产出标本,优化BRBPS检测的临床使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Broad-range bacterial polymerase chain reaction with sequencing (BRBPS) provides valuable diagnostic data, especially in cases of culture-negative infections. However, as BRBPS testing demonstrates generally low positivity, cost per impactful result can be high and commonly involves longer turnaround times compared with other methods, targeting use of this assay to high-yield situations remains a challenging goal. Diagnostic stewardship can help alleviate these challenges and increase clinical utility, yet not all laboratories have a dedicated stewardship team, and little formal guidance exists on identifying high-yield samples outside of specific clinical syndromes. In this study, we performed a retrospective review of 86 BRBPS orders from a tertiary care medical center, with a focus on identifying high-yield cases using an infectious markers scoring system, visualized inflammation or organism (VIO) score, to predict return of actionable diagnostic data. METHODS: Using chart review, we evaluated how results from high VIO score or low VIO score specimens contributed to clinical management. RESULTS: Testing low VIO score samples identified an organism in only 10% of samples, and of these positive results, 33% were considered to represent contamination. Despite negative routine workup and no identified pathogen via BRBPS, broad antimicrobial treatment was continued in 85% of cases with a low VIO score. In contrast, specimens with high VIO scores were more predictably positive by BRBPS, identified organisms that were universally considered pathogens, and provided opportunities to target or de-escalate antimicrobial therapy. CONCLUSIONS: This study describes the VIO scoring system to guide the identification of high-yield samples and steward the appropriate use of BRBPS testing.

来源:Am J Clin Pathol,查看原文。版权归原作者所有。

引用

  1. Dumm RE, Glaser LJ, Rodino KG, et al. Development of a scoring system to identify high-yield specimens for bacterial broad-range 16S rRNA gene PCR with sequencing at a tertiary care medical center. Am J Clin Pathol. 2023. PMID: 37458096. doi:10.1093/ajcp/aqad074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。